Wednesday starts with Admiral William McRaven and wraps with a fireside chat with FDA Commissioner Robert Califf, always an ...

Wednesday starts with Admiral William McRaven and wraps with a fireside chat with FDA Commissioner Robert Califf, always an ...

But when it comes to software, there is an art to utilising these advanced capabilities that results in a value-add, rather ...

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary ...

Currently, there is no FDA-approved treatment for the devastating neurodegenerative disease, which cuts the average lifespan ...

At ASCO, Eli Lilly, Genfleet Therapeutics and InxMed all presented new clinical data on KRAS G12C inhibitors in non-small ...

NHS hospitals in London have declared a critical incident caused by a ransomware attack on a pathology services provider, ...

FDA independent advisors have comprehensively voted against the use of Lykos Therapeutics’ therapy for post-traumatic stress ...

In our work with clients, we have experienced several common organisational pain points in integrating market access into ...

pharmaphorum is back at the BIO International Convention this year, coming to you from sunny San Diego with two days of live ...

The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a ...

ViVE always offers an excellent opportunity to register the pulse of the digital healthcare industry and learn from the ...